Stride, Inc.
LRN
$83.54
-14.50%
Stride, Inc. is a leading American online educational company operating in the Education & Training Services industry, providing alternative K-12 programs to traditional on-campus schooling through state-funded virtual charter schools and curriculum agreements with school districts. The company has established itself as a dominant platform in the virtual K-12 education sector, leveraging its scale and technology to serve a growing demand for flexible learning models. The current investor narrative is dominated by severe volatility and a significant stock price decline from its highs, as highlighted by a major fund's recent liquidation of its position, which points to intense debate over near-term execution risks versus the potential for a high-risk, high-reward turnaround given the stock's depressed valuation and reportedly resolved platform issues.…
LRN
Stride, Inc.
$83.54
Investment Opinion: Should I buy LRN Today?
Rating & Thesis: Hold. LRN is a fundamentally sound company caught in a severe sentiment and technical downdraft, making it a high-risk, high-potential-reward situation unsuitable for a clear Buy rating until technical recovery is confirmed. The single analyst EPS estimate of $9.66 implies significant growth, but without a consensus price target, the implied upside is unclear.
Supporting Evidence: The valuation is the primary attraction, with a forward P/E of 10.63x and a PEG ratio of 0.55 suggesting deep undervaluation if growth estimates are met. Profitability is strong (15.76% net margin) and improving, with gross margin expansion of 190 bps YoY. The balance sheet is a pillar of strength, with a 5.39 current ratio and $209.7M in TTM FCF. Revenue growth, while positive at 7.5% YoY, needs to accelerate to rebuild the growth narrative.
Risks & Conditions: The two biggest risks are a failure to sustain the recent price recovery, leading to a retest of the $60 low, and another quarter of volatile earnings that erodes the forward P/E thesis. This Hold would upgrade to a Buy on a sustained technical breakout above the recent high near $102, signaling a reversal of the downtrend, or if the forward P/E compresses further towards 8x without a deterioration in fundamentals. It would downgrade to a Sell if revenue growth decelerates below 5% or if the stock breaks below $80 support on high volume. Relative to its own history and growth-adjusted metrics, the stock appears undervalued, but it is fairly valued given the substantial execution and sentiment risks it carries.
Sign up to view all
LRN 12-Month Price Forecast
LRN is a conflicted story where compelling valuation and fundamentals clash with broken price action and weak sentiment. The low forward P/E offers significant upside if execution improves, but the path is fraught with volatility. The base case of a grinding recovery is most likely, given the company's operational strength but persistent investor skepticism. The stance would upgrade to Bullish on a confirmed technical breakout above $102 accompanied by stable quarterly growth. It would downgrade to Bearish if the stock loses its recent momentum and falls below $80, signaling a failure of the recovery attempt.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Stride, Inc.'s 12-month outlook, with a consensus price target around $108.60 and implied upside of +30.0% versus the current price.
Average Target
$108.60
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$67 - $109
Analyst target range
Analyst coverage appears limited, with data indicating only one analyst providing estimates for revenue and EPS, which suggests insufficient broad institutional coverage to form a reliable consensus; this typically implies the stock is a mid-cap name with lower visibility, leading to potentially higher volatility and less efficient price discovery. The available data shows a single analyst revenue estimate averaging $3.13 billion and an EPS estimate of $9.66, but without a consensus price target or Buy/Hold/Sell distribution, the implied sentiment cannot be gauged; the recent institutional ratings show a mix of 'Outperform/Buy' and 'Market Perform/Equal Weight' actions, with one notable downgrade from Outperform to Market Perform in late October 2025, indicating some analyst caution emerged around that period.
Bulls vs Bears: LRN Investment Factors
The evidence presents a classic battleground stock scenario. The bull case is grounded in strong fundamentals: robust profitability, a pristine balance sheet, compelling forward valuation, and sustained revenue growth. The bear case is anchored in severe technical damage, low institutional confidence, high short interest, and recent execution missteps. Currently, the bearish technical and sentiment indicators hold stronger near-term evidence, as the stock remains deeply wounded from its highs despite recent stabilization. The single most important tension is whether the company's solid fundamentals and low forward P/E (10.63x) can overcome the significant loss of investor confidence and technical breakdown. The resolution of this confidence gap will determine if LRN is a value trap or a turnaround story.
Bullish
- Strong Profitability & Margin Expansion: The company is solidly profitable with a net margin of 15.76% in the latest quarter, up from 11.08% in the prior quarter. Gross margin expanded to 41.13% from 39.20% YoY, demonstrating improved operational efficiency and pricing power.
- Robust Financial Health & Cash Generation: Stride boasts a fortress balance sheet with a current ratio of 5.39 and a low debt-to-equity ratio of 0.37. The company generated $209.7 million in TTM free cash flow, funding growth internally and supporting a high ROE of 19.46%.
- Compelling Forward Valuation: The stock trades at a forward P/E of only 10.63x, a steep discount to its trailing P/E of 21.70x, implying the market expects significant earnings growth. The PEG ratio of 0.55 suggests the stock is undervalued relative to its growth prospects.
- Sustained Revenue Growth Trajectory: Revenue grew 7.5% YoY in Q2 FY2026 to $631.3 million, continuing a trend of sequential quarterly growth from $520.8 million in Q3 FY2024. This indicates the core business is expanding despite near-term volatility.
Bearish
- Severe Price Decline & Technical Damage: The stock is down 38.23% over the past year and trades 54% below its 52-week high of $171.17, indicating a broken long-term uptrend. The 52-week low of $60.61 represents a -35% downside risk from the current price of $93.08.
- Limited Analyst Coverage & Sentiment: Only one analyst provides estimates, indicating low institutional visibility and potentially inefficient price discovery. Recent news highlights a major fund liquidating its position, and an analyst downgraded the stock in October 2025, signaling professional caution.
- High Short Interest & Skepticism: The short ratio is elevated at 9.63, suggesting a significant portion of the market is betting on further price declines. This creates a potential overhang and risk of a short squeeze if the thesis reverses, but currently reflects deep skepticism.
- Volatile Earnings & Execution Risk: Net income swung from $99.5 million in Q2 FY2026 to $68.8 million in Q1 FY2026, indicating quarterly earnings volatility. The recent news specifically cites 'severe near-term execution risk' as a key concern for investors.
LRN Technical Analysis
The stock is in a pronounced downtrend over the past year, evidenced by a 1-year price change of -38.23%, and is currently trading at approximately 54% of its 52-week range (current price $93.08 vs. 52-week high $171.17 and low $60.61), indicating it is positioned in the lower half of its annual band and suggesting a value opportunity but with significant technical damage. Recent momentum shows a stark divergence, with the stock up 4.75% over the past month and 10.02% over the past three months, which signals a potential stabilization or nascent recovery attempt after the severe longer-term decline; however, this short-term strength is underperforming the broader market, as indicated by a relative strength of -5.23 over one month. Key technical support is anchored at the 52-week low of $60.61, while major resistance sits at the 52-week high of $171.17; a sustained move above the recent high near $102 would be needed to signal a more meaningful reversal, while the stock's beta of 0.049 indicates it has exhibited dramatically lower volatility than the market, which is an unusual characteristic that may reflect idiosyncratic risk or a period of extreme price dislocation.
Beta
0.08
0.08x market volatility
Max Drawdown
-64.1%
Largest decline past year
52-Week Range
$61-$171
Price range past year
Annual Return
-41.7%
Cumulative gain past year
| Period | LRN Return | S&P 500 |
|---|---|---|
| 1m | -5.4% | +2.1% |
| 3m | -4.1% | +12.5% |
| 6m | +26.3% | +12.4% |
| 1y | -41.7% | +26.4% |
| ytd | +29.3% | +10.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LRN Fundamental Analysis
Revenue growth remains positive but has shown some quarterly variability; the most recent quarterly revenue (Q2 FY2026) was $631.3 million, representing a 7.5% year-over-year increase, and this follows a trend of sequential quarterly revenue growth from $520.8 million in Q3 FY2024, indicating a sustained expansion trajectory. The company is solidly profitable, with net income of $99.5 million in the latest quarter and a gross margin of 41.13%, which has expanded from 39.20% in the year-ago quarter, demonstrating improving operational efficiency and pricing power; the net margin for the quarter was a healthy 15.76%. The balance sheet is robust with a strong current ratio of 5.39 and a manageable debt-to-equity ratio of 0.37, while the company generated substantial free cash flow of $209.7 million (TTM) and an ROE of 19.46%, indicating it is funding growth internally and delivering solid returns on shareholder equity.
Quarterly Revenue
$631261000.0B
2025-12
Revenue YoY Growth
+0.07%
YoY Comparison
Gross Margin
+0.41%
Latest Quarter
Free Cash Flow
$209743380.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LRN Overvalued?
Given the company's consistent profitability (Net Income > 0), the primary valuation metric is the P/E ratio. The trailing P/E is 21.70x, while the forward P/E is significantly lower at 10.63x, implying the market expects a substantial increase in earnings, which aligns with analyst EPS estimates averaging $9.66 for the coming period. Compared to sector averages (data not provided in the input), a direct peer comparison cannot be quantified; however, a trailing P/E in the low 20s for a company with mid-teens net margins and positive growth could be considered reasonable depending on the industry benchmark. Historically, the stock's own trailing P/E has fluctuated significantly, ranging from approximately 7.05x to over 30x in recent quarters; the current reading of 21.70x sits above the lower end of this range but well below the highs, suggesting the market is pricing in a recovery but remains cautious relative to past optimism.
PE
21.7x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -64x~98x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Stride's primary financial risk is not leverage or cash burn, but rather earnings volatility and dependence on continued execution to justify a recovery. Net income fell 31% sequentially from Q2 to Q1 FY2026 ($99.5M to $68.8M), highlighting potential lumpiness in profitability. Revenue concentration in state-funded virtual charter schools and district contracts exposes the company to regulatory and funding changes. While the balance sheet is strong (D/E 0.37), the valuation relies on forward earnings growth materializing; a miss could compress the forward P/E multiple rapidly.
Market & Competitive Risks: The stock trades at a significant discount to its own historical valuation (trailing P/E of 21.70x vs. past highs over 30x), but this compression may persist if growth fears are not alleviated. The education sector faces perennial regulatory scrutiny and potential budget pressures. The stock's beta of 0.049 indicates it has decoupled from the market, but this is a double-edged sword—it may not benefit from broad market rallies and is subject to its own unique narrative. Recent news of a major fund's exit underscores the competitive risk for investor attention and capital in a mid-cap name with limited coverage.
Worst-Case Scenario: The worst-case scenario involves a failure to stabilize enrollment or margins, leading to consecutive earnings misses, analyst downgrades, and a loss of the remaining investor patience. This could trigger a sell-off back to the 52-week low of $60.61, representing a -35% decline from the current price of $93.08. Given the stock's history of a -64.07% max drawdown, such a move is within the realm of historical volatility. A sustained break below $60 could see the stock re-test levels from its pre-recovery phase, potentially resulting in a total loss of 50% or more from current levels for investors who buy now.
FAQ
The key risks are, in order of severity: 1) Sentiment & Technical Risk: The stock is down 38% over the past year and faces high short interest, indicating a severe loss of confidence that could lead to further declines toward the $60.61 low (-35% downside). 2) Execution & Volatility Risk: Quarterly earnings have been volatile (net income fell 31% sequentially), and any miss could crush the low forward P/E thesis. 3) Market & Coverage Risk: With only one analyst providing estimates, the stock suffers from low visibility and inefficient price discovery, making it prone to exaggerated moves. 4) Sector Risk: As a provider of state-funded online education, it is subject to regulatory and budgetary changes that could impact revenue.
The 12-month forecast is bifurcated, with a 50% probability base case target range of $90-$110, a 30% probability bull case target of $120-$140, and a 20% probability bear case target of $60-$80. The base case, which is most likely, assumes the company meets its forward EPS estimate of ~$9.66, leading to gradual multiple stabilization but not significant expansion. The key assumption is that management executes consistently to rebuild investor trust. The wide range of outcomes reflects the stock's current status as a battleground between strong fundamentals and weak technicals/sentiment.
Based on forward-looking metrics, LRN appears significantly undervalued. Its forward P/E of 10.63x and PEG ratio of 0.55 suggest the market is pricing in minimal growth despite analyst expectations for substantial earnings expansion. Compared to its own historical trailing P/E range (approximately 7x to 30x), the current trailing multiple of 21.70x is in the mid-range, but the forward multiple is near the low end. The market is paying a discount that implies deep skepticism about the company's ability to execute and grow. Therefore, the stock is undervalued if the growth materializes, but fairly valued given the substantial execution risk it carries.
LRN is a high-risk, high-potential-reward stock that may be a good buy for a specific investor profile. For a risk-tolerant, patient investor who believes the company's strong fundamentals (15.76% net margin, 10.63x forward P/E) will eventually overcome recent sentiment issues, the current price could be an attractive entry point. However, given the 38% annual decline, high short interest (9.63), and lack of broad analyst coverage, it is not a good buy for conservative investors. The key is believing in the management's execution to deliver on the implied $9.66 EPS, which offers significant upside if achieved.
LRN is primarily suitable for a long-term investment horizon of 2-3 years. The company's issues are related to sentiment and technical recovery, which typically take multiple quarters to resolve. Its near-zero beta (0.049) and high volatility make it a poor short-term trading vehicle, as price movements are driven by company-specific news rather than market trends. Furthermore, the investment thesis relies on the realization of forward earnings growth, which is a multi-quarter process. A long-term horizon allows patient investors to potentially capture the valuation upside if the turnaround succeeds, while weathering the inevitable volatility along the way.
